Battle between Indian Companies and Global Giants

The ultra powerful pharmaceutical multi nationals are facing a setback due to India’s weak patent regime for medicines. India has been favoring the low cost Indian generic companies. Also, recently the Indian patent office granted compulsory license allowing Natco Pharma Ltd to make and sell a copy of German drug maker Bayer AG’s patented [...]